Cargando…
The risk of long-term cardiometabolic disease in women with premature or early menopause: A systematic review and meta-analysis
BACKGROUND: Transition into menopause is associated with an increased risk of cardiovascular disease (CVD). However, it is unclear whether the association exists between premature menopause (defined as age at menopause 40 years) or early menopause (defined as age at menopause 40–45 years) and CVD or...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072266/ https://www.ncbi.nlm.nih.gov/pubmed/37025693 http://dx.doi.org/10.3389/fcvm.2023.1131251 |
_version_ | 1785019347492667392 |
---|---|
author | Liu, Jiajun Jin, Xueshan Liu, Wenbin Chen, Wanying Wang, Lan Feng, Ziyi Huang, Jieming |
author_facet | Liu, Jiajun Jin, Xueshan Liu, Wenbin Chen, Wanying Wang, Lan Feng, Ziyi Huang, Jieming |
author_sort | Liu, Jiajun |
collection | PubMed |
description | BACKGROUND: Transition into menopause is associated with an increased risk of cardiovascular disease (CVD). However, it is unclear whether the association exists between premature menopause (defined as age at menopause 40 years) or early menopause (defined as age at menopause 40–45 years) and CVD or cardiovascular risk factors. The aim of this review was to comprehensively evaluate and meta-analyze the most reliable evidence about the relationship between menopausal age and the risk of long-term cardiometabolic disease. METHODS: A comprehensive literature search of the PubMed, Web of Science, and Embase databases from inception to October 1, 2022, for titles and abstracts with a restriction to English language papers led to the discovery of the studies. Data are expressed as the Hazard Ratio (HR) with 95% confidence intervals (CI). The degree of heterogeneity was measured using the I-square (I(2)) index. RESULTS: 921,517 participants from 20 cohort studies published between 1998 and 2022 were considered. Compared to women with menopause at age >45 years, women with premature menopause (PM) or early menopause (EM) had a higher risks of type 2 diabetes (RR: 1.32, 95% CI: 1.08–1.62; RR: 1.11, 95% CI: 0.91–1.36, respectively), hyperlipidemia (RR: 1.21, 95% CI: 1.05–1.39; RR: 1.17, 95% CI: 1.02–1.33, respectively), coronary heart disease (RR: 1.52, 95% CI: 1.22–1.91; RR: 1.19, 95% CI: 1.07–1.32, respectively), stroke (RR: 1.27, 95% CI: 1.02–1.58; RR: 1.13, 95% CI: 0.97–1.32, respectively) and total cardiovascular event (RR: 1.36, 95% CI: 1.16–1.60; RR: 1.14, 95% CI: 0.97–1.35, respectively). No difference was found for hypertension in PM or EM women (RR: 0.98, 95% CI: 0.89–1.07; RR: 0.97, 95% CI: 0.91–1.04, respectively). Additionally, we also found that PM women, but not EM women, were linked with an increased risk of ischemic and hemorrhagic stroke. However, this is not in line with the conclusion that both PM and EM had a higher risk of total stroke. CONCLUSION: Women with PM or EM have a higher risk of developing long-term CVD, compared to women with menopause at age >45 years. Therefore, we recommend early lifestyle interventions (e.g., maintaining a healthy lifestyle) and medical treatments (e.g., timely initiation of menopausal hormone therapy) to decrease the risk of cardiometabolic disease in early or premature menopausal women. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, identifier CRD42022378750 |
format | Online Article Text |
id | pubmed-10072266 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100722662023-04-05 The risk of long-term cardiometabolic disease in women with premature or early menopause: A systematic review and meta-analysis Liu, Jiajun Jin, Xueshan Liu, Wenbin Chen, Wanying Wang, Lan Feng, Ziyi Huang, Jieming Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Transition into menopause is associated with an increased risk of cardiovascular disease (CVD). However, it is unclear whether the association exists between premature menopause (defined as age at menopause 40 years) or early menopause (defined as age at menopause 40–45 years) and CVD or cardiovascular risk factors. The aim of this review was to comprehensively evaluate and meta-analyze the most reliable evidence about the relationship between menopausal age and the risk of long-term cardiometabolic disease. METHODS: A comprehensive literature search of the PubMed, Web of Science, and Embase databases from inception to October 1, 2022, for titles and abstracts with a restriction to English language papers led to the discovery of the studies. Data are expressed as the Hazard Ratio (HR) with 95% confidence intervals (CI). The degree of heterogeneity was measured using the I-square (I(2)) index. RESULTS: 921,517 participants from 20 cohort studies published between 1998 and 2022 were considered. Compared to women with menopause at age >45 years, women with premature menopause (PM) or early menopause (EM) had a higher risks of type 2 diabetes (RR: 1.32, 95% CI: 1.08–1.62; RR: 1.11, 95% CI: 0.91–1.36, respectively), hyperlipidemia (RR: 1.21, 95% CI: 1.05–1.39; RR: 1.17, 95% CI: 1.02–1.33, respectively), coronary heart disease (RR: 1.52, 95% CI: 1.22–1.91; RR: 1.19, 95% CI: 1.07–1.32, respectively), stroke (RR: 1.27, 95% CI: 1.02–1.58; RR: 1.13, 95% CI: 0.97–1.32, respectively) and total cardiovascular event (RR: 1.36, 95% CI: 1.16–1.60; RR: 1.14, 95% CI: 0.97–1.35, respectively). No difference was found for hypertension in PM or EM women (RR: 0.98, 95% CI: 0.89–1.07; RR: 0.97, 95% CI: 0.91–1.04, respectively). Additionally, we also found that PM women, but not EM women, were linked with an increased risk of ischemic and hemorrhagic stroke. However, this is not in line with the conclusion that both PM and EM had a higher risk of total stroke. CONCLUSION: Women with PM or EM have a higher risk of developing long-term CVD, compared to women with menopause at age >45 years. Therefore, we recommend early lifestyle interventions (e.g., maintaining a healthy lifestyle) and medical treatments (e.g., timely initiation of menopausal hormone therapy) to decrease the risk of cardiometabolic disease in early or premature menopausal women. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, identifier CRD42022378750 Frontiers Media S.A. 2023-03-21 /pmc/articles/PMC10072266/ /pubmed/37025693 http://dx.doi.org/10.3389/fcvm.2023.1131251 Text en © 2023 Liu, Jin, Liu, Chen, Wang, Feng and Huang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Liu, Jiajun Jin, Xueshan Liu, Wenbin Chen, Wanying Wang, Lan Feng, Ziyi Huang, Jieming The risk of long-term cardiometabolic disease in women with premature or early menopause: A systematic review and meta-analysis |
title | The risk of long-term cardiometabolic disease in women with premature or early menopause: A systematic review and meta-analysis |
title_full | The risk of long-term cardiometabolic disease in women with premature or early menopause: A systematic review and meta-analysis |
title_fullStr | The risk of long-term cardiometabolic disease in women with premature or early menopause: A systematic review and meta-analysis |
title_full_unstemmed | The risk of long-term cardiometabolic disease in women with premature or early menopause: A systematic review and meta-analysis |
title_short | The risk of long-term cardiometabolic disease in women with premature or early menopause: A systematic review and meta-analysis |
title_sort | risk of long-term cardiometabolic disease in women with premature or early menopause: a systematic review and meta-analysis |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072266/ https://www.ncbi.nlm.nih.gov/pubmed/37025693 http://dx.doi.org/10.3389/fcvm.2023.1131251 |
work_keys_str_mv | AT liujiajun theriskoflongtermcardiometabolicdiseaseinwomenwithprematureorearlymenopauseasystematicreviewandmetaanalysis AT jinxueshan theriskoflongtermcardiometabolicdiseaseinwomenwithprematureorearlymenopauseasystematicreviewandmetaanalysis AT liuwenbin theriskoflongtermcardiometabolicdiseaseinwomenwithprematureorearlymenopauseasystematicreviewandmetaanalysis AT chenwanying theriskoflongtermcardiometabolicdiseaseinwomenwithprematureorearlymenopauseasystematicreviewandmetaanalysis AT wanglan theriskoflongtermcardiometabolicdiseaseinwomenwithprematureorearlymenopauseasystematicreviewandmetaanalysis AT fengziyi theriskoflongtermcardiometabolicdiseaseinwomenwithprematureorearlymenopauseasystematicreviewandmetaanalysis AT huangjieming theriskoflongtermcardiometabolicdiseaseinwomenwithprematureorearlymenopauseasystematicreviewandmetaanalysis AT liujiajun riskoflongtermcardiometabolicdiseaseinwomenwithprematureorearlymenopauseasystematicreviewandmetaanalysis AT jinxueshan riskoflongtermcardiometabolicdiseaseinwomenwithprematureorearlymenopauseasystematicreviewandmetaanalysis AT liuwenbin riskoflongtermcardiometabolicdiseaseinwomenwithprematureorearlymenopauseasystematicreviewandmetaanalysis AT chenwanying riskoflongtermcardiometabolicdiseaseinwomenwithprematureorearlymenopauseasystematicreviewandmetaanalysis AT wanglan riskoflongtermcardiometabolicdiseaseinwomenwithprematureorearlymenopauseasystematicreviewandmetaanalysis AT fengziyi riskoflongtermcardiometabolicdiseaseinwomenwithprematureorearlymenopauseasystematicreviewandmetaanalysis AT huangjieming riskoflongtermcardiometabolicdiseaseinwomenwithprematureorearlymenopauseasystematicreviewandmetaanalysis |